【2024最新】5大加拿大網卡推薦比較，加拿大SIM卡怎麼挑怎麼買一次帶你看！

Long | 合法藥品大搜索

Long

由KYokoyama著作·2019·被引用15次—Secondaryhyperparathyroidism(SHPT)isacommoncomplicationofchronickidneydisease(CKD),andasthediseaseprogressesSHPTis ...

 Long

This study and preparation of the manuscript was sponsored by Kyowa Hakko Kirin Co., Ltd. K.Y. received consulting fees and lecture fees from Kyowa Hakko Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd. and Torii Pharmaceutical Co., Ltd. M.F. has received consulting fees from Kyowa Hakko Kirin Co., Ltd. and Ono Pharmaceutical Co., Ltd., and lecture fees from Kyowa Hakko Kirin Co., Ltd., Bayer Yakuhin, Ltd., Torii Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd., and grants from Kyowa Hakko Kirin Co., Ltd. and Bayer Yakuhin, Ltd. T.A. has received consulting fees from Kyowa Hakko Kirin Co., Ltd., Astellas Pharma Inc., Bayer Yakuhin, Ltd., Fuso Pharmaceutical Industries, Ltd., Japan Tobacco Inc., Ono Pharmaceutical Co., Ltd. and NIPRO Industry, and lecture fees from Kyowa Hakko Kirin Co., ...

閱讀更多

evocalcet fda Evocalcet orkedia etelcalcetide 旁必福 Parsabiv 旁必福parsabiv 旁必福價格 Etelcalcetide Cinacalcet cinacalcet價錢 銳 克 鈣 售 價 evocalcet fda Evocalcet orkedia etelcalcetide lorazepam副作用 優良安靜錠的副作用 sulfamethoxazole眼藥水 Phel Powder for Injection 機 轉 嘉 南 有限公司 氧氣 鋼瓶 袋 安/腸溶錠２０公絲（鳳梨酵素） Clotrimazole 500mg 用法
Evocalcet: A New Oral Calcimimetic for Dialysis ... | 合法藥品大搜索
由 T Akizawa 著作 · 2020 · 被引用 8 次 — It is the newest calcimimetic in the world and was developed in Japan with the aim of resolving the issues of the upper GI effects, drug–drug interactions, and ... Read More
Pharmacodynamics of evocalcet for secondary ... | 合法藥品大搜索
由 T Shigematsu 著作 · 2019 · 被引用 11 次 — Multiple doses of evocalcet reduced intact PTH levels with a concomitant decrease in serum calcium levels. Evocalcet was well tolerated in SHPT ... Read More
Evocalcet | 合法藥品大搜索
由 T Akizawa 著作 · 被引用 8 次 — Patients with chronic kidney disease often develop secondary hyperparathyroidism (SHPT), marked by high levels of circulating parathyroid hormone (PTH) and ... Read More
Head | 合法藥品大搜索
由 M Fukagawa 著作 · 2018 · 被引用 38 次 — Keywords: Japan; cinacalcet; evocalcet; gastrointestinal; randomized controlled trial; secondary hyperparathyroidism. Copyright © 2018 ... Read More
Long | 合法藥品大搜索
由 K Yokoyama 著作 · 2019 · 被引用 15 次 — Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), and as the disease progresses SHPT is ... Read More
Long | 合法藥品大搜索
由 K Yokoyama 著作 · 2019 · 被引用 15 次 — Evocalcet is a novel calcimimetic developed as an equally efficacious, but more tolerable, alternative to the currently available ... Read More
Evocalcet | 合法藥品大搜索
Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist. Read More
Evocalcet | 合法藥品大搜索
Evocalcet is an orally available calcium receptor (CaR) modulator, with potential calcimimetic activity. Upon administration, evocalcet allosterically binds ... Read More
Evocalcet | 合法藥品大搜索
由 T Akizawa 著作 · 2020 · 被引用 8 次 — It is the newest calcimimetic in the world and was developed in Japan with the aim of resolving the issues of the upper GI effects, drug–drug ... Read More
Pharmacokinetics of evocalcet in secondary ... | 合法藥品大搜索
由 T Shigematsu 著作 · 2018 · 被引用 10 次 — Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan ... Read More
相關資訊整理

【福祿鈣片】缺鈣、齲齒

藥品名稱:福祿鈣片許可證字號:內衛藥製字第008220號許可證種類:製　劑適應症:缺鈣、齲齒劑型:藥品類別:醫師藥師藥劑生指示藥...

【鈣易清膜衣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:鈣易清膜衣錠25毫克許可證字號:衛部藥製字第058545號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢...

【銳克鈣錠75毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:銳克鈣錠75毫克許可證字號:衛署藥輸字第025140號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...

【銳克鈣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:銳克鈣錠25毫克許可證字號:衛署藥輸字第025141號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...

【旁必福注射液】PARSABIV適用於治療罹患慢性腎臟病 (CKD) 且接受血液透析之成人病人的次發性副甲狀腺機能亢進 (secondary HPT)。

藥品名稱:旁必福注射液許可證字號:衛部藥輸字第027639號許可證種類:製　劑適應症:PARSABIV適用於治療罹患慢性腎臟病(CKD)且...